Quantcast

Crispus Attucks

Search

Criteria
Show Calendar Clear Calendar
 
Results
Sort By: Date
18 article(s) found. Displaying article(s) 1 - 10.
2  ››

PhRMA Staff
Rx Minute / PhRMA / September 22, 2009
A March 2009 report by Deloitte, examines the incentives needed to sustain the discovery of new biologics that should be considered in establishing an abbreviated ... (read more)

Dan Miller
News Release / The Heartland Institute / June 22, 2009
Congress is exploring legislation that would create a new drug-approval process in the Food and Drug Administration for what are called “biosimilars,” ... (read more)

Richard Dolinar, M.D.
Heartland Policy Brief / The Heartland Institute / June 18, 2009
Congress is currently exploring legislation that would create a new drug approval process in the U.S. Food and Drug Administration for what are called follow-on ... (read more)

Dan Miller
News Release / The Heartland Institute / January 27, 2009
The California Supreme Court last week refused to review a controversial Court of Appeal ruling that decreed the manufacturer of a "pioneer" drug ... (read more)

Michele Forzley, JD, MPH
Concept Paper / World Health Organization / January 27, 2006
Counterfeit drugs are a global public health problem causing death, disability and injury affecting adults and children. No country is free of this problem, ... (read more)

Onkar Ghate
Fraser Forum / The Fraser Institute / June 01, 2005

Brett J. Skinner
Fraser Forum / The Fraser Institute / June 01, 2005

Richard A. Epstein and Bruce N. Kuhlik
Regulation Magazine / Cato Institute / June 01, 2004

Tomas J. Philipson and Carolanne Dai
Regulation / Cato Institute / October 01, 2003

John R. Graham
Fraser Forum / The Fraser Institute / October 01, 2003